Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
03/1998
03/17/1998US5728736 Applying an arginase inhibitor to the skin
03/17/1998US5728716 Trachykinin peptide for nervous system disorders and cardiovascular disorders
03/17/1998US5728708 Pharmacologically active pyridine derivatives and processes for the preparation thereof
03/17/1998US5728688 Therapeutic methods and delivery systems utilizing sex steroid precursors
03/17/1998US5728686 Alkylxanthine phosphonates and alkylxanthine phosphine oxides and their use as pharmaceuticals
03/17/1998US5728683 Whitening effect
03/17/1998US5728677 Administering a specified polypeptide to a mammal
03/17/1998US5728553 High purity albumin and method of producing
03/17/1998US5728541 Screening therapeutic or chemotherapeutic agents for efficacy as to a specific patient
03/17/1998US5728392 Cosmetic and/or dermatological composition for the treatment of aging, containing ceramides, and the use thereof
03/17/1998US5728391 Hyaluronic acid and its salt for treating skin diseases
03/17/1998US5728373 Cosmetic and dermatological sunscreen compositions containing thiols and/or thiol derivates
03/17/1998CA1339724C Anti-inflammatory factor, method of isolation, and use
03/12/1998WO1998009985A2 Anti-inflammatory peptides and uses thereof
03/12/1998WO1998009980A1 Bh3 interacting domain death agonist
03/12/1998WO1998009977A1 Tetrahydronapthalene derivatives and their therapeutic use
03/12/1998WO1998009969A1 Novel aryl-pyridazines
03/12/1998WO1998009961A1 Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
03/12/1998WO1998009957A1 Compounds for and a method of inhibiting matrix metalloproteinases
03/12/1998WO1998009940A1 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
03/12/1998WO1998009934A1 Matrix metalloproteinase inhibitors and their therapeutic uses
03/12/1998WO1998009630A1 Compounds and methods
03/12/1998WO1998009626A1 Methods for in vivo reduction of iron levels and compositions useful therefor
03/12/1998WO1997049827A3 Adenoviral mediated gene transfer in adipocytes and related implants
03/12/1998DE19638745A1 Monoklonale Antikörper gegen die extrazelluläre Domäne des menschlichen VEGF - Rezeptorproteins (KDR) Monoclonal antibodies against the extracellular domain of the human VEGF - receptor protein (KDR)
03/12/1998DE19636689A1 Neue Benzamidinderivate New benzamidine derivatives
03/12/1998CA2264942A1 Compounds and methods
03/12/1998CA2264798A1 Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
03/12/1998CA2264737A1 Tetrahydronaphthalene derivatives and their therapeutic use
03/12/1998CA2264578A1 Bh3 interacting domain death agonist
03/12/1998CA2264285A1 Anti-inflammatory peptides and uses thereof
03/12/1998CA2263686A1 Methods for in vivo reduction of iron levels and compositions useful therefor
03/12/1998CA2263586A1 Novel aryl-pyridazines
03/12/1998CA2256716A1 Matrix metalloproteinase inhibitors and their therapeutic uses
03/12/1998CA2256631A1 Compounds for and a method of inhibiting matrix metalloproteinases
03/11/1998EP0827743A1 Use of histone decarboxylase inhibitors for treating fibrosis
03/11/1998EP0827742A1 Use of histone deacetylase inhibitors for treating fribosis or cirrhosis
03/11/1998EP0827401A2 Methods and compositions for inhibiting alpha-reductase activity
03/11/1998EP0827400A2 Use of a pharmaceutically acceptable oxalate derivative in the manufacture of a medicament for the treatment of skin conditions
03/11/1998EP0827395A1 Topically applicable agents for treating and preventing alopecia
03/11/1998EP0827392A1 Cosmetic or dermatological preparations containing phytic acid
03/11/1998EP0759070A4 Blood-borne mesenchymal cells
03/11/1998EP0663902B1 25-carboxylic acid derivatives in the vitamin d series, pharmaceutical preparations containing these derivatives and their use in the manufacture of medicines
03/11/1998EP0662946B1 Unsaturated aliphatic dicarboxylic acids
03/11/1998EP0556178B1 Use of protease nexin-i to mediate wound healing
03/11/1998CN1175976A Arachidonic acid and method for production and use thereof
03/11/1998CN1175957A Monoclonal antibodies anti-CD6 and their uses
03/11/1998CN1175573A Vitamin D3 analogs
03/11/1998CN1175416A Wart curing paste
03/11/1998CN1175403A Anti-inflammatory, antipruritic and prickly-heat-expelling skin liquid
03/10/1998US5726305 Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates
03/10/1998US5726298 Epimorphin and its encoding nucleic acids
03/10/1998US5726191 Aromatic carboxylic acid esters
03/10/1998US5726183 Use of quinoline-3-carboxamide compounds
03/10/1998CA1339706C Prophylactic and therapeutic compositions comtrising benzilic acid for against acne and oily skin
03/05/1998WO1998008859A1 Bioconjugates and delivery of bioactive agents
03/05/1998WO1998008853A1 Phosphinic acid amides as matrix metalloprotease inhibitors
03/05/1998WO1998008850A1 Spirocyclic metalloprotease inhibitors
03/05/1998WO1998008847A1 Substituted 6,5-hetero-bicyclic derivatives
03/05/1998WO1998008827A1 Heterocyclic metalloprotease inhibitors
03/05/1998WO1998008825A1 1,4-heterocyclic metalloprotease inhibitors
03/05/1998WO1998008823A1 Heterocyclic metalloprotease inhibitors
03/05/1998WO1998008822A1 1,3-diheterocyclic metalloprotease inhibitors
03/05/1998WO1998008815A1 Substituted cyclic amine metalloprotease inhibitors
03/05/1998WO1998008814A1 Bidentate metalloprotease inhibitors
03/05/1998WO1998008550A1 Fragmented polymeric hydrogels for adhesion prevention and their preparation
03/05/1998WO1998008546A2 Therapeutic combinations of rar antagonists and rxr agonists and use thereof
03/05/1998WO1998008533A1 Sustained peptide-release formulation
03/05/1998WO1998008529A1 Method of inhibiting fibrosis with a somatostatin agonist
03/05/1998WO1998008528A1 Method of inhibiting fibrosis with a somatostatin agonist
03/05/1998WO1998008503A1 Therapeutic methods and compositions involving isoflavones
03/05/1998WO1998002548A3 Infectious papillomavirus pseudoviral particles
03/05/1998WO1998002452A3 Compounds and methods for modulating cell adhesion
03/05/1998WO1997037688A3 Pharmaceutical combination containing a compound having angiotensin ii and antagonistic activity
03/05/1998DE19635359A1 Skin care lotions in the form of oil in water emulsions
03/05/1998CA2265049A1 Therapeutic methods and compositions involving isoflavones
03/05/1998CA2264309A1 Method of inhibiting fibrosis with a somatostatin agonist
03/05/1998CA2264266A1 1,3-diheterocyclic metalloprotease inhibitors
03/05/1998CA2264045A1 Heterocyclic metalloprotease inhibitors
03/05/1998CA2264044A1 Spirocyclic metalloprotease inhibitors
03/05/1998CA2263932A1 1,4-heterocyclic metalloprotease inhibitors
03/05/1998CA2263928A1 Substituted cyclic amine metalloprotease inhibitors
03/05/1998CA2263917A1 Heterocyclic metalloprotease inhibitors
03/05/1998CA2263914A1 Bidentate metalloprotease inhibitors
03/05/1998CA2263817A1 Therapeutic combinations of rar antagonists and rxr agonists and use thereof
03/04/1998EP0826774A2 Staphylococcal Fab I enoyl-ACP reductase
03/04/1998EP0826668A1 Derivatives of 2-imino-2,3-dihydro-1H-indole and their use in hair dyeing compositions
03/04/1998EP0826657A1 Compounds for modulation of hormone receptors, compositions containing them and their use in therapy
03/04/1998EP0826368A1 Use of retinoids for the preparation of a medicament for treating disorders related to VEGF overexpression
03/04/1998EP0826367A2 Use of an extract of Bertholletia in cosmetics or in pharmaceuticals, and for the preparation of cell-culture media
03/04/1998EP0826365A2 Tocopheryl ascorbyl phosphate-cyclodextrin clathrate and a topical dermal composition containing said clathrate
03/04/1998EP0826041A1 Transforming growth factor alpha hii
03/04/1998CN1175263A Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
03/04/1998CN1175213A Irrigation solution and method for inhibition of pain, inflammation
03/04/1998CN1174727A Medicinal preparation for removing comedones and face caring
03/04/1998CN1174724A Application of patchouli oil used as germicide for skin
03/03/1998US5723707 Dehydrogenation processes, equipment and catalyst loads therefor
03/03/1998US5723583 Antibody containing sialyl lewis X determinants
03/03/1998US5723499 Polycyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof
03/03/1998US5723482 Active compounds and cosmetic and dermatological formulations
1 ... 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 ... 1065